tiprankstipranks
Advertisement
Advertisement

CRDL Stock Latest News

Cardiol Therapeutics’ Phase II Pericarditis Data in JAHA Bolsters Near-Complete Phase III MAVERIC Trial
Company AnnouncementsCardiol Therapeutics’ Phase II Pericarditis Data in JAHA Bolsters Near-Complete Phase III MAVERIC Trial
15d ago
6K
CRDL
Cardiol Therapeutics’ CardiolRx featured in Phase 2 pericarditis published trial
PremiumThe Fly
Cardiol Therapeutics’ CardiolRx featured in Phase 2 pericarditis published trial
16d ago
CRDL
Cardiol Therapeutics to Highlight CardiolRx Programs at B. Riley Mind, Muscle & Vision Summit
PremiumCompany Announcements
Cardiol Therapeutics to Highlight CardiolRx Programs at B. Riley Mind, Muscle & Vision Summit
21d ago
6K
CRDL
Cardiol Therapeutics Shareholders Back Board Slate and Auditor at 2026 AGM
PremiumCompany Announcements
Cardiol Therapeutics Shareholders Back Board Slate and Auditor at 2026 AGM
1M ago
6K
CRDL
Cardiol Therapeutics to Webcast June 24 Virtual AGM as Late-Stage Cardiac Programs Advance
PremiumCompany Announcements
Cardiol Therapeutics to Webcast June 24 Virtual AGM as Late-Stage Cardiac Programs Advance
1M ago
6K
CRDL
Cardiol Therapeutics Sets June 24, 2026 Virtual AGM and Adopts Notice-and-Access for Proxy Materials
PremiumCompany AnnouncementsCardiol Therapeutics Sets June 24, 2026 Virtual AGM and Adopts Notice-and-Access for Proxy Materials
2M ago
6K
CRDL
Cardiol Therapeutics to Present Pipeline at H.C. Wainwright BioConnect Conference at NASDAQ
Premium
Company Announcements
Cardiol Therapeutics to Present Pipeline at H.C. Wainwright BioConnect Conference at NASDAQ
3M ago
6K
CRDL
Cardiol Therapeutics Reports Higher Q1 2026 Loss but Stronger Cash Position
Premium
Company Announcements
Cardiol Therapeutics Reports Higher Q1 2026 Loss but Stronger Cash Position
3M ago
6K
CRDL
Cardiol Therapeutics’ Phase II MAvERIC Pericarditis Data Accepted by JAHA as Phase III Trial Nears Completion
PremiumCompany Announcements
Cardiol Therapeutics’ Phase II MAvERIC Pericarditis Data Accepted by JAHA as Phase III Trial Nears Completion
3M ago
6K
CRDL
Cardiol Therapeutics expands U.S. MAVERIC Phase III trial network
PremiumThe Fly
Cardiol Therapeutics expands U.S. MAVERIC Phase III trial network
3M ago
CRDL
Cardiol Therapeutics Expands U.S. Phase III MAVERIC Trial Network as Enrollment Reaches 75%
PremiumCompany Announcements
Cardiol Therapeutics Expands U.S. Phase III MAVERIC Trial Network as Enrollment Reaches 75%
3M ago
6K
CRDL
Cardiol Therapeutics Showcases MAVERIC Phase III Trial and ARCHER Results in Barchart Live Interview
PremiumCompany Announcements
Cardiol Therapeutics Showcases MAVERIC Phase III Trial and ARCHER Results in Barchart Live Interview
4M ago
6K
CRDL
Cardiol Therapeutics Sets June 24, 2026 Date for Annual General Meeting of Shareholders
PremiumCompany AnnouncementsCardiol Therapeutics Sets June 24, 2026 Date for Annual General Meeting of Shareholders
4M ago
6K
CRDL
Cardiol Therapeutics Details 2025 Progress and Funding for Late-Stage Cardiac Drug Programs
Premium
Company Announcements
Cardiol Therapeutics Details 2025 Progress and Funding for Late-Stage Cardiac Drug Programs
4M ago
6K
CRDL
CRDL Upcoming Earnings Report: What to Expect?
Premium
Pre-Earnings
CRDL Upcoming Earnings Report: What to Expect?
4M ago
CRDL
Cardiol Therapeutics to Present Cardiovascular Pipeline Update at TD Cowen Health Care Conference
PremiumCompany Announcements
Cardiol Therapeutics to Present Cardiovascular Pipeline Update at TD Cowen Health Care Conference
5M ago
6K
CRDL
Cardiol Therapeutics’ ARCHER Phase II Myocarditis Data Published in ESC Heart Failure
PremiumCompany Announcements
Cardiol Therapeutics’ ARCHER Phase II Myocarditis Data Published in ESC Heart Failure
6M ago
6K
CRDL
Cardiol Therapeutics Secures $14.85 Million Bought-Deal Unit Financing
PremiumCompany Announcements
Cardiol Therapeutics Secures $14.85 Million Bought-Deal Unit Financing
6M ago
6K
CRDL
Cardiol Therapeutics Secures $13.5 Million Bought-Deal Financing to Advance Heart Disease Programs
PremiumCompany Announcements
Cardiol Therapeutics Secures $13.5 Million Bought-Deal Financing to Advance Heart Disease Programs
6M ago
6K
CRDL
Cardiol Therapeutics Raises $14.85 Million in Bought-Deal Financing to Support Late-Stage Heart Disease Programs
PremiumCompany AnnouncementsCardiol Therapeutics Raises $14.85 Million in Bought-Deal Financing to Support Late-Stage Heart Disease Programs
6M ago
CRDL
Cardiol Therapeutics Secures $13.5 Million Bought Deal Financing to Advance Heart Disease Programs
Premium
Company Announcements
Cardiol Therapeutics Secures $13.5 Million Bought Deal Financing to Advance Heart Disease Programs
6M ago
CRDL
Cardiol Therapeutics trading resumes
Premium
The Fly
Cardiol Therapeutics trading resumes
6M ago
CRDL

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >